These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 36237421

  • 1. PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by Francisella tularensis LVS.
    Cantlay S, Kaftanic C, Horzempa J.
    Front Cell Infect Microbiol; 2022; 12():979693. PubMed ID: 36237421
    [Abstract] [Full Text] [Related]

  • 2. OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in Francisella tularensis LVS.
    Cantlay S, Haggerty K, Horzempa J.
    J Bacteriol; 2020 Jun 25; 202(14):. PubMed ID: 32366588
    [Abstract] [Full Text] [Related]

  • 3. Disruption of Francisella tularensis Schu S4 iglI, iglJ, and pdpC genes results in attenuation for growth in human macrophages and in vivo virulence in mice and reveals a unique phenotype for pdpC.
    Long ME, Lindemann SR, Rasmussen JA, Jones BD, Allen LA.
    Infect Immun; 2013 Mar 25; 81(3):850-61. PubMed ID: 23275090
    [Abstract] [Full Text] [Related]

  • 4. The Role and Mechanism of Erythrocyte Invasion by Francisella tularensis.
    Schmitt DM, Barnes R, Rogerson T, Haught A, Mazzella LK, Ford M, Gilson T, Birch JW, Sjöstedt A, Reed DS, Franks JM, Stolz DB, Denvir J, Fan J, Rekulapally S, Primerano DA, Horzempa J.
    Front Cell Infect Microbiol; 2017 Mar 25; 7():173. PubMed ID: 28536678
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic characterization of the Francisella tularensis ΔpdpC and ΔiglG mutants.
    Ozanic M, Marecic V, Lindgren M, Sjöstedt A, Santic M.
    Microbes Infect; 2016 Dec 25; 18(12):768-776. PubMed ID: 27477000
    [Abstract] [Full Text] [Related]

  • 6. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA.
    Infect Immun; 2010 Oct 25; 78(10):4341-55. PubMed ID: 20643859
    [Abstract] [Full Text] [Related]

  • 7. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.
    Ulland TK, Janowski AM, Buchan BW, Faron M, Cassel SL, Jones BD, Sutterwala FS.
    Infect Immun; 2013 Jan 25; 81(1):201-8. PubMed ID: 23115038
    [Abstract] [Full Text] [Related]

  • 8. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC.
    Infect Immun; 2006 Aug 25; 74(8):4452-61. PubMed ID: 16861631
    [Abstract] [Full Text] [Related]

  • 9. Unique substrates secreted by the type VI secretion system of Francisella tularensis during intramacrophage infection.
    Bröms JE, Meyer L, Sun K, Lavander M, Sjöstedt A.
    PLoS One; 2012 Aug 25; 7(11):e50473. PubMed ID: 23185631
    [Abstract] [Full Text] [Related]

  • 10. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galić S, Horwitz MA.
    Vaccine; 2016 Sep 22; 34(41):4969-4978. PubMed ID: 27577555
    [Abstract] [Full Text] [Related]

  • 11. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
    Cole LE, Shirey KA, Barry E, Santiago A, Rallabhandi P, Elkins KL, Puche AC, Michalek SM, Vogel SN.
    Infect Immun; 2007 Aug 22; 75(8):4127-37. PubMed ID: 17517865
    [Abstract] [Full Text] [Related]

  • 12. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 13. A method for functional trans-complementation of intracellular Francisella tularensis.
    Steele S, Taft-Benz S, Kawula T.
    PLoS One; 2014 May 10; 9(2):e88194. PubMed ID: 24505427
    [Abstract] [Full Text] [Related]

  • 14. Type VI Secretion System and Its Effectors PdpC, PdpD, and OpiA Contribute to Francisella Virulence in Galleria mellonella Larvae.
    Brodmann M, Schnider ST, Basler M.
    Infect Immun; 2021 Jun 16; 89(7):e0057920. PubMed ID: 33875476
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
    Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW.
    Infect Immun; 2013 Sep 16; 81(9):3099-105. PubMed ID: 23774604
    [Abstract] [Full Text] [Related]

  • 16. Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages.
    Bradford MK, Elkins KL.
    Sci Rep; 2020 Jul 21; 10(1):12023. PubMed ID: 32694562
    [Abstract] [Full Text] [Related]

  • 17. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
    Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W.
    PLoS One; 2013 Jul 21; 8(11):e78671. PubMed ID: 24236032
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D, Uda A, Park ES, Hotta A, Fujita O, Yamada A, Hirayama K, Hotta K, Koyama Y, Azaki M, Morikawa S.
    Microbiol Immunol; 2018 Jan 21; 62(1):24-33. PubMed ID: 29171073
    [Abstract] [Full Text] [Related]

  • 19. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
    Jia Q, Bowen R, Sahakian J, Dillon BJ, Horwitz MA.
    Infect Immun; 2013 May 21; 81(5):1550-61. PubMed ID: 23439306
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.